Zobrazeno 1 - 4
of 4
pro vyhledávání: '"BIOBADASER Group"'
Publikováno v:
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
instname
The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d1d41cb7c5a79bc87b95f35839a272ba
https://hdl.handle.net/10347/22955
https://hdl.handle.net/10347/22955
Publikováno v:
Arthritis & Rheumatism: Arthritis Care & Research; Jun2007, Vol. 57 Issue 5, p756-761, 6p
Autor:
Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M, BIOBADASER Group
Publikováno v:
Arthritis & Rheumatism; Jun2005, Vol. 52 Issue 6, p1766-1772, 7p
Autor:
Jl, Peña-Sagredo, Mv, Hernández, Fernandez-Llanio N, Giménez-Ubeda E, Muñoz-Fernandez S, Ortiz A, Ma, Gonzalez-Gay, Mc, Fariñas, Biobadaser group
Publikováno v:
Europe PubMed Central
The prognosis of patients with rheumatic diseases has improved considerably following the use of biological therapies. However, an increase in the frequency of bacterial infections has been observed in patients receiving these therapies. In the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::282641fd6ef0c6730c16ddabf6c51057
http://europepmc.org/abstract/med/19032819
http://europepmc.org/abstract/med/19032819